Leading pediatric endocrinologist and scientist, Dr. David Weinstein moved his world-renowned GSD program from the University of Florida to UConn Health and Connecticut Children’s Medical Center in January 2017.
Weinstein’s GSD Program is the largest clinical and research program of its kind in the world. Pediatric and adult patients living with the rare, genetic liver disease travel from across the U.S. and the globe for his and his team’s expert care. Dr. Weinstein follows the largest number of GSD patients in the world caring for more than 500 patients traveling from 49 states and 45 countries.
The Glycogen Storage Disease Type 6 Fund at UConn was created to support GSD Type 6 research at UConn Health.